Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas

Endocrine Pathology

Volumn 15, Issue 2, 2004, Pages 117-129

  Tanaka, Yasushi ^a   Sano, Toshiaki ^a   Zhi, Rong Qian ^a   Hirokawa, Mitsuyoshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

catenin; catenin; Adhesion molecules; Chromogranin A; Cytokeratin 20; E cadherin; Immunohistochemistry; Merkel cell carcinoma

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CELL ADHESION MOLECULE; CYTOKERATIN 20; UVOMORULIN;

ADULT; AGED; ARTICLE; CELL MEMBRANE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HEAD; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPAN; LYMPHOCYTIC INFILTRATION; MALE; MERKEL CELL TUMOR; NECK; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; ALPHA CATENIN; BETA CATENIN; CADHERINS; CARCINOMA, MERKEL CELL; CELL ADHESION MOLECULES; CHROMOGRANIN A; CHROMOGRANINS; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; MALE; MIDDLE AGED; SKIN NEOPLASMS; STATISTICS, NONPARAMETRIC; TRANS-ACTIVATORS;

EID: 4444375545     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:15:2:117     Document Type: Article

References (34)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 105:107-110, 1972.
2. Tang CK, Toker C. Trabecular carcinoma of the skin: further clinicopathologic and ultrastructural study. Mt Sinai J Med 46:516-523, 1979.
3. Wick MR, Goellner JR, Scheithauer BW, Thomas JR 3rd, Sanchez NP, Schroeter AL. Primary neuroendocrine carcinomas of the skin (Merkel cell tumors). A clinical, histologic, and ultrastructural study of thirteen cases. Am J Clin Pathol 79:6-13, 1983.
4. Cooper L, Debono R, Alsanjari N, Al-Nafussi A. Merkel cell tumour with leiomyosarcomatous differentiation. Histopathology 36:540-543, 2000.
5. Skelton HG, Smith KJ, Hitchcock CL, McCarthy WF, Lupton GP, Graham JH. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 37(5 Pt 1):734-739, 1997.
6. Alvarez-Gago T, Bullon MM, Rivera F, Velasco A, Mayo A. Intermediate filament aggregates in mitoses of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Histopathology 28:349-355, 1996.
7. Scott MP, Helm KF. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Am J Dermatopathol 21:16-20, 1999.
8. Jensen K, Kohler S, Rouse RV. Cytokeratin staining in Merkel cell carcinoma: an immunohistochemical study of cytokeratins 5/6, 7, 17, and 20. Appl Immunohistochem Mol Morphol 8:310-315, 2000.
9. Horvath E, Kovacs K. Morphogenesis and significance of fibrous bodies in human pituitary adenomas. Virchows Arch B Cell Pathol 27:69-78, 1978.
10. Perez-Montiel MD, Frankel WL, Suster S. Neuroendocrine carcinomas of the pancreas with "Rhabdoid" features. Am J Surg Pathol 27:642-649, 2003.
11. Shimazaki H, Aida S, Sato M, Deguchi H, Ozeki Y, Tamai S. Lung carcinoma with rhabdoid cells: a clinicopathological study and survival analysis of 14 cases. Histopathology 38:425-434, 2001.
12. Saito T, Oda Y, Itakura E, et al. Expression of intercellular adhesion molecules in epithelioid sarcoma and malignant rhabdoid tumor. Pathol Int 51:532-542, 2001.
13. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153:333-339, 1998.
14. Li CC, Xu B, Hirokawa M, et al. Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract. Virchows Arch 440:145-154, 2002.
15. Berx G, Nollet F, van Roy F. Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes Commun 6:171-184, 1998.
16. Clavel CE, Nollet F, Berx G, et al. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours. J Pathol 194:20-26, 2001.
17. Nakopoulou L, Gakiopoulou-Givalou H, Karayiannakis AJ, et al. Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival. Histopathology 40:536-546, 2002.
18. Reed RJ, Argenyi Z. Tumors of Neural Tissue. In: Elder D, ed. Lever's histopathology of the skin. 8th ed. Philadelphia, PA: Lippincott-Raven, 1997; 1000-1002.
19. Han AC, Soler AP, Tang CK, Knudsen KA, Salazar H. Nuclear localization of E-cadherin expression in Merkel cell carcinoma. Arch Pathol Lab Med 124:1147-1151, 2000.
20. Qian ZR, Li CC, Yamasaki H, et al. Role of E-cadherin, alpha-, beta-, and gamma-catenins, and p120 (cell adhesion molecules) in prolactinoma behavior. Mod Pathol 15:1357-1365, 2002.
21. Fei Q, Zhang H, Chen X, et al. Defected expression of E-cadherin in non-small cell lung cancer. Lung Cancer 37:147-152, 2002.
22. Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology 36:692-701, 2002.
23. Horiguchi T, Sano T, Qian ZR, et al. Expression of cell adhesion molecules in chordomas: An immunohistochemical study of 16 cases. Acta Neuropathol (Berl) 107:91-96, 2003.
24. Xu B, Sano T, Yoshimoto K, Yamada S. Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies. Endocr Pathol 13:341-351, 2002.
25. Said JW, Vimadalal S, Nash G, et al. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol 16:236-240, 1985.
26. Okano K, Maeba T, Moroguchi A, et al. Lymphocytic infiltration surrounding liver metastases from colorectal cancer. J Surg Oncol 82:28-33, 2003.
27. Chan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 21:226-234, 1997.
28. Hall PA, d'Ardenne AJ, Butler MG, et al. Cytokeratin and laminin immunostaining in the diagnosis of cutaneous neuro-endocrine (Merkel cell) tumours. Histopathology 10:1179-1190, 1986.
29. Moll I, Kuhn C, Moll R. Cytokeratin 20 is a general marker of cutaneous Merkel cells while certain neuronal proteins are absent. J Invest Dermatol 104:910-915, 1995.
30. Wick MR. Immunohistology of neuroendocrine and neuroectodermal tumors. Semin Diagn Pathol. 17:194-203, 2000.
31. Rosai J. Skin. In: Rosai J, ed. Ackerman's surgical pathology. 8th ed. St. Louis, MO: Mosby, 1996; 166-168.
32. Baschinsky DY, Niemann TH, Eaton LA, Frankel WL. Malignant mixed Mullerian tumor with rhabdoid features: a report of two cases and a review of the literature. Gynecol Oncol 73:145-150, 1999.
33. Mazal PR, Czech T, Sedivy R, et al. Prognostic relevance of intracytoplasmic cytokeratin cattern, hormone expression profile, and cell proliferation in pituitary adenomas of acromegalic patients. Clin Neuropathol. 20:163-171, 2001.
34. Sano T, Ohshima T, Yamada S. Expression of glycoprotein hormones and intracytoplasmic distribution of cytokeratin in growth hormone-producing pituitary adenomas. Pathol Res Pract 187:530-533, 1991.